This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $1750 | In Stock |
500mg | $2750 | In Stock |
1g | $4125 | In Stock |
Cat #: V4134 CAS #: 81846-19-7 Purity ≥ 98%
Description: Treprostinil (LRX-15; trade names: Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation), a synthetic analog of prostacyclin (PGI2), is a novel and potent DP1 and EP2 agonist with EC50 values of 0.6±0.1 and 6.2±1.2 nM, respectively.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 390.51 |
---|---|
Molecular Formula | C23H34O5 |
CAS No. | 81846-19-7 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent |
Protocol | In Vitro | Treprostinil has high affinity for the DP1, EP2 and IP receptors (Ki=4.4, 3.6 and 32 nM, respectively), low affinity for EP1 and EP4 receptors and even lower affinity for EP3, FP and TP receptors. Activation of IP, DP1 and EP2 receptors, as with treprostinil, can all result in vasodilatation of human pulmonary arteries |
---|
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 2.5608 mL | 12.8038 mL | 25.6075 mL | 51.2151 mL |
5mM | 0.5122 mL | 2.5608 mL | 5.1215 mL | 10.2430 mL |
10mM | 0.2561 mL | 1.2804 mL | 2.5608 mL | 5.1215 mL |
20mM | 0.1280 mL | 0.6402 mL | 1.2804 mL | 2.5608 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.